MAX BioPharma
MAX BioPharma a biotechnology start-up company pioneering the burgeoning field of lipidomics.
- Stage Concept Only
- Industry Biotechnology
- Location Los Angeles, CA, USA
- Currency USD
- Employees 5
- Website maxbiopharma.com
Company Summary
MAX will be a leader in the new field of “lipidomics” and “oxysterol therapeutics” by leveraging a growing portfolio of novel molecules / drug candidates that will lead to treatments for numerous diseases. These molecules present significant opportunities for inhibiting the growth of human cancer cells as well as stimulating bone growth in osteoporosis patients.
Team
-
Farhad ParhamiFounder and President
Farhad Parhami was trained as a Molecular and Cellular Pathologist in the Department of Pathology at UCLA under the mentorship of Professor Judith Berliner. His training and experience include molecular and cellular biology, lipid metabolism, inflammation, and bone and vascular biology. In 1996 he obtained a faculty position and currently holds the title of Professor-in-Residence in the Department of Medicine at UCLA. His research laboratory at U
-
Zachary CotnerDirector of Finance and Corporate Strategy
Zachary Cotner is the Director of Finance & Strategy at MAX BioPharma. He has over 8 years of corporate finance experience in investment banking and private equity and has completed numerous transactions in the capital markets. Some of his former notable clients include such companies as Dex One Corp, TerreStar Corp., NextWave Wireless Inc., and Reichhold Inc. Most recently, Mr. Cotner was an investment banker in Houlihan Lokey’s Special Situatio
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.